This HTML5 document contains 164 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.2165/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q39306047
rdf:type
wikibase:Item
schema:description
bài báo khoa học 2009年學術文章 artykuł naukowy scienca artikolo artikull shkencor artigo científico (publicado na 2009) 2009年學術文章 vědecký článek wissenschaftlicher Artikel vedecký článok vetenskaplig artikel мақолаи илмӣ наукова стаття, опублікована в січні 2009 2009年学术文章 article scientific articol științific videnskabelig artikel (udgivet 2009) научни чланак artigo científico artigo científico (publicado na 2009) 2009年學術文章 ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vitskapeleg artikkel სამეცნიერო სტატია scientific article naučni članak мақолаи илмӣ wetenschappelijk artikel научни чланак 2009年の論文 article científic tudományos cikk 2009年學術文章 2009年学术文章 2009年学术文章 научная статья 2009年學術文章 article scientifique (publié 2009) 2009年学术文章 vitenskapelig artikkel سائنسی مضمون articolo scientifico מאמר מדעי mokslinis straipsnis artikulong pang-agham 2009 nî lūn-bûn artículo científico publicado en 2009 2009年學術文章 مقالة علمية نشرت في عام 2009 επιστημονικό άρθρο artículu científicu espublizáu en 2009 научна статия գիտական հոդված 2009年学术文章 teaduslik artikkel บทความทางวิทยาศาสตร์ tieteellinen artikkeli 2009년 논문 bilimsel makale مقالهٔ علمی
p:P577
wds:Q39306047-58F6F599-CAC2-42BC-B97F-4E2F45DB7FCB
wdt:P577
2009-01-01T00:00:00Z
p:P2860
wds:Q39306047-3159E932-5861-4FE4-BCEA-BC4321954FFC wds:Q39306047-34C28E31-F3C7-4702-B88E-84B316D19AE6 wds:Q39306047-37A8F215-D3B5-4810-BFAE-C37682FE8DE6 wds:Q39306047-3B5B03E1-05E2-49AD-AC70-04FACEACFEA0 wds:Q39306047-4D587789-013B-4CA7-A9AD-4215FCD97654 wds:Q39306047-54CBC3BD-409A-4523-B93F-6729EB26248D wds:Q39306047-0D43E969-847B-45B6-9040-FEB756215A12 wds:Q39306047-1796E6E7-5E5B-4753-BCE2-A8622F957BE5 wds:Q39306047-17999048-E908-4F35-9D52-2436E1BF42F1 wds:Q39306047-18450568-04F7-4C20-868F-71451FD9A52B wds:Q39306047-206FDFAC-D005-4C63-9D57-CA042B28E063 wds:Q39306047-2846E4CE-07F7-4DC5-971C-F91EA01479F6 wds:Q39306047-2B97F8BA-5CAC-4AE7-B434-D8D01B891FC4 wds:Q39306047-2C5E94CF-7401-4EFA-AE1B-1305801DD654 wds:Q39306047-9EAFF2B7-860F-4C03-8356-0B119E9629B7 wds:Q39306047-A6E3F8AA-F327-4D5E-9B4C-EB8DFBFF4EC8 wds:Q39306047-A7D382B7-CE0E-4BA8-8769-737C5443103A wds:Q39306047-B47282FF-9D61-41A6-9731-EF9B127843C8 wds:Q39306047-745C8EE7-E7FD-41A5-A5CC-16631DD85516 wds:Q39306047-772B60BE-DCC5-4EBB-A103-8A1E527B7941 wds:Q39306047-87525E26-55B2-4C43-8349-197430E06027 wds:Q39306047-EFF91E27-6951-4E99-A270-177727F6050C wds:Q39306047-F2A3A5D9-75C3-4C52-B482-1940DEC1DDD0 wds:Q39306047-F51FEC55-A389-46EF-B811-52AD571AD333 wds:Q39306047-FC81B00B-4C51-4FC9-BEF6-0E4250022963 wds:Q39306047-FDC9938A-4BFE-4EE4-85FB-61146EFDC1AB wds:Q39306047-C34E9B64-4FB1-4420-894B-C02FA1635517 wds:Q39306047-D26ED6C8-5965-4990-B68F-DCCA090B21A3 wds:Q39306047-E449BD0C-988E-40E0-87E3-DD46A1F11B27
wdt:P2860
wd:Q39368431 wd:Q79798143 wd:Q36280904 wd:Q37283665 wd:Q39438845 wd:Q73214494 wd:Q44946961 wd:Q80981295 wd:Q39388670 wd:Q46787750 wd:Q39466132 wd:Q49049732 wd:Q52364596 wd:Q34699259 wd:Q33199137 wd:Q83646704 wd:Q44411545 wd:Q45185821 wd:Q36298665 wd:Q27860916 wd:Q48823789 wd:Q41501755 wd:Q24680820 wd:Q44843017 wd:Q39355231 wd:Q35994723 wd:Q39377711 wd:Q39395734 wd:Q24245455
p:P2093
wds:Q39306047-463B79F0-7CA4-4D64-BEB9-8198FE9F0B3C wds:Q39306047-BB33FAAF-D9A9-4B2A-84CF-03BAA1E98527 wds:Q39306047-ACA59763-0AD7-42A7-B3F3-B2DCF9F65A93 wds:Q39306047-8CC7D2FE-CD16-4B18-844E-ECDAED9D2469 wds:Q39306047-638328DE-C74D-468C-9264-3FBE0AEAAD52
wdt:P2093
Michael Serpell Ilona Steigerwald Göran Leijon Ralf Baron Andreas Binder
rdfs:label
Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled tri Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled tri Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled tri
skos:prefLabel
Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled tri Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled tri Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled tri
schema:name
Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled tri Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled tri Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled tri
p:P50
wds:Q39306047-BECA6DAE-838E-4CCC-BB7D-9C516794125E
wdt:P50
wd:Q80820711
p:P1476
wds:Q39306047-EE1F9333-8371-4D38-95D5-0AD30CF1897E
wdt:P1476
Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial
p:P304
wds:Q39306047-ED976C23-108B-4294-9DCC-4D903185C5E3
wdt:P304
231-241
p:P31
wds:Q39306047-E102434D-B9AD-4273-B1A7-AFBA0F21F384
wdt:P31
wd:Q13442814
p:P921
wds:Q39306047-CDBFC72A-A7E3-4498-BEC8-485D67C2442D wds:Q39306047-9FB88D55-FA3F-4477-A2AF-07D180C0C6A4
wdt:P921
wd:Q4160985 wd:Q216935
p:P698
wds:Q39306047-8CFEDDF8-2410-493E-AF23-DF3303893371
wdtn:P698
n12:19301937
wdt:P698
19301937
p:P1433
wds:Q39306047-58E8DDBF-BADE-4A10-BC0C-9C368226704D
wdt:P1433
wd:Q15753215
p:P433
wds:Q39306047-D6410C8B-8F2A-4BCC-BFF2-DB4FCBE77907
p:P478
wds:Q39306047-ADAE5817-F097-4FD2-AE63-05F26274F688
wdt:P433
4
wdt:P478
29
p:P356
wds:Q39306047-543F6B8A-F6CE-4200-B554-304E5E8A34E0
wdtn:P356
n11:00044011-200929040-00002
wdt:P356
10.2165/00044011-200929040-00002